Sophont Launches Holon-S1 to Reveal Tumor Biology from Routine Pathology Slides

San Francisco Chronicle · 2026-10-20 17:49 UTC

Sophont, a frontier medical AI startup, announces Holon-S1, a pan-cancer AI model that predicts spatial gene and biological pathway activity from routine hematoxylin and eosin (H&E) pathology

Read the full story at San Francisco Chronicle · All coverage of this story